You will see that the Mesoblast Briefing Info document, both in layout and content, dovetails precisely with the FDA material.
Split in two. Manufacturing and Efficacy.
The Agenda x 2, the Experts x 2, the FDA Briefing Info documents x 2, the Questions x 2.
Mesoblast has been hand in hand with the FDA during the whole process.
Then skip to our conclusions addressing their issues. I think it is quite compelling.
GLTAH!
PS Having Dr Joanne Kurtzberg present is the master stroke
You will see that the Mesoblast Briefing Info document, both in...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.57 |
Change
-0.210(11.8%) |
Mkt cap ! $1.792B | |||
| Open | High | Low | Value | Volume |
| $1.72 | $1.74 | $1.52 | $15.63M | 9.716M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5127 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.57 | 39613 | 3 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |